Robert  DeSantis net worth and biography

Robert DeSantis Biography and Net Worth

Bob DeSantis is Executive Vice President & Chief Product Officer at Intuitive. He leads the global teams that develop and manufacture the company’s three robotic platforms—multiport, single port, and endoluminal—all novel platforms that are designed to help enable better outcomes for patient populations around the world. He is also responsible for global operations, program management, technical services, user experience, and product management.

Mr. DeSantis joined Intuitive in 2013 as Vice President, Instruments & Accessories New Product Introduction. His role was later expanded to include leading the product development, marketing, engineering, and operations teams for the instruments, accessories, and endoscope portfolios. DeSantis has also played a key role in the expansion and scaling of Intuitive’s global manufacturing operations. Most recently, he was the Executive Vice President and General Manager of Instruments, Accessories, and Endoscopes, leading the global teams that design, manufacture, and market the company’s robust portfolio of products.

DeSantis started his career at U.S. Surgical where he was part of the research team that developed laparoscopic technologies that enabled the first wave of minimally invasive surgery. Later as part of Covidien, he served as VP of R&D for Surgical Devices leading the mechanical and energy devices organizations. He also led the group that developed and first commercialized single incision laparoscopic surgery (SILS).

DeSantis earned a B.S. and M.S. in Mechanical Engineering from the State University of New York, Buffalo. He also holds a Certificate in Innovation Management from the Massachusetts Institute of Technology.

What is Robert DeSantis' net worth?

The estimated net worth of Robert DeSantis is at least $2.16 million as of March 8th, 2024. Mr. DeSantis owns 5,507 shares of Intuitive Surgical stock worth more than $2,162,158 as of March 18th. This net worth evaluation does not reflect any other investments that Mr. DeSantis may own. Additionally, Mr. DeSantis receives a salary of $1,120,000.00 as EVP at Intuitive Surgical. Learn More about Robert DeSantis' net worth.

How old is Robert DeSantis?

Mr. DeSantis is currently 58 years old. There are 6 older executives and no younger executives at Intuitive Surgical. The oldest executive at Intuitive Surgical is Mr. Marshall L. Mohr, Executive Vice President of Global Business Services, who is 68 years old. Learn More on Robert DeSantis' age.

What is Robert DeSantis' salary?

As the EVP of Intuitive Surgical, Inc., Mr. DeSantis earns $1,120,000.00 per year. There are 4 executives that earn more than Mr. DeSantis. The highest earning executive at Intuitive Surgical is Dr. Gary S. Guthart Ph.D., CEO & Director, who commands a salary of $2,230,000.00 per year. Learn More on Robert DeSantis' salary.

How do I contact Robert DeSantis?

The corporate mailing address for Mr. DeSantis and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Robert DeSantis' contact information.

Has Robert DeSantis been buying or selling shares of Intuitive Surgical?

During the past quarter, Robert DeSantis has sold $8,120,927.44 of Intuitive Surgical stock. Most recently, Robert Desantis sold 329 shares of the business's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $390.16, for a transaction totalling $128,362.64. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company's stock, valued at $2,148,611.12. Learn More on Robert DeSantis' trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 35 times. They sold a total of 433,677 shares worth more than $151,620,634.99. The most recent insider tranaction occured on March, 11th when EVP Robert Desantis sold 329 shares worth more than $128,362.64. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 3/11/2024.

Robert DeSantis Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2024Sell329$390.16$128,362.645,507View SEC Filing Icon  
3/8/2024Sell20,296$393.80$7,992,564.805,507View SEC Filing Icon  
11/14/2023Sell867$290.00$251,430.007,259View SEC Filing Icon  
10/24/2023Sell1,110$273.49$303,573.907,259View SEC Filing Icon  
7/25/2023Sell2,535$323.26$819,464.107,259View SEC Filing Icon  
6/14/2023Sell2,443$325.00$793,975.007,259View SEC Filing Icon  
1/27/2023Sell1,629$250.00$407,250.006,769View SEC Filing Icon  
1/25/2022Sell1,410$261.64$368,912.40View SEC Filing Icon  
8/26/2021Sell397$1,048.12$416,103.64761View SEC Filing Icon  
7/23/2021Sell4,004$967.26$3,872,909.043,462View SEC Filing Icon  
2/17/2021Sell2,958$782.00$2,313,156.00
7/24/2020Sell1,798$666.21$1,197,845.583,348View SEC Filing Icon  
See Full Table

Robert DeSantis Buying and Selling Activity at Intuitive Surgical

This chart shows Robert Desantis's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $392.62
Low: $390.79
High: $401.27

50 Day Range

MA: $380.18
Low: $330.56
High: $400.59

2 Week Range

Now: $392.62
Low: $237.58
High: $403.00

Volume

1,653,977 shs

Average Volume

1,734,510 shs

Market Capitalization

$139.16 billion

P/E Ratio

78.06

Dividend Yield

N/A

Beta

1.36